Jonathan Kfoury

Jonathan Kfoury is a former Managing Director, Partner, and Partner Emeritus with L.E.K. Consulting, focused on life sciences and healthcare. During his tenure with the firm he held several leadership roles and led an extensive set of engagements with global biopharmaceutical, medical technology and healthcare / health system clients, as well as emerging and leading non-profit organizations focused in global health and access. Jonathan focused much of his advisory work on commercial strategy, R&D planning, organizational scale-up and growth / partnering strategy.

Among extensive broader experience in oncology, immunology, neurology and rare diseases, Jonathan has been active in the infectious disease space for over 15 years. In particular, Jonathan has published and spoken extensively across the industry on the crisis of antimicrobial resistance (AMR), barriers to investment into novel antibiotics, public/private partnership and key opportunities for innovators within anti-infectives more broadly.

Prior to joining L.E.K., Jonathan was a Business Development executive at several biopharma organizations, and manager of global Clinical Development for Cubist Pharmaceuticals’ (now Merck) blockbuster antibiotic Cubicin® – the most successful IV antibiotic launched in US history. In addition to global management training at INSEAD, Jonathan earned an S.M. in Health Policy & Management from Harvard University, and graduated from Trinity College with a Bachelor of Science degree in Neuroscience. Beyond work Jonathan is a jazz, blues, and rock musician (piano / keys), and loves getting into deep nature with wife and four kids.